Back
Verisk Analytics Vs. Novartis AG Industry Stock Comparison
Buy
61
VRSK
Verisk Analytics
Last Price:
$291.04
Seasonality Move:
5.59%
Buy
70
NVSEF
Novartis AG
Last Price:
$107.55
Seasonality Move:
6.56%
Buy
61
Verisk Analytics (VRSK)
is a Buy
Is Verisk Analytics a Buy, Sell or Hold?
-
The current Verisk Analytics [VRSK] share price is $287.76. The Score for VRSK is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
VRSK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $116.60. The Score for NVSEF is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VRSK Stock Price Chart
What is Verisk Analytics's stock price today?
-
The Verisk Analytics share price today is $287.76Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRSK is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $116.60Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVSEF is experiencing slight buying pressure.
VRSK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.07 | Sell |
Relative Strength Index (14 RSI): | 45.86 | Sell |
Chaikin Money Flow: | 931672 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (287.74 - 297.16) | Sell |
Bollinger Bands (100): | (276.54 - 293.24) | Buy |
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.09 | Buy |
Relative Strength Index (14 RSI): | 61.26 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (107.28 - 114.3) | Buy |
Bollinger Bands (100): | (98.5 - 109.54) | Buy |
VRSK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 288.03 | Sell |
20-day SMA: | 292.03 | Sell |
50-day SMA: | 288.38 | Sell |
200-day SMA: | 277.14 | Buy |
8-day EMA: | 288.12 | Sell |
20-day EMA: | 290.12 | Sell |
50-day EMA: | 288.67 | Sell |
200-day EMA: | 275.12 | Buy |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 111.91 | Buy |
20-day SMA: | 111.76 | Buy |
50-day SMA: | 106.31 | Buy |
200-day SMA: | 106.86 | Buy |
8-day EMA: | 113.26 | Buy |
20-day EMA: | 111.23 | Buy |
50-day EMA: | 107.91 | Buy |
200-day EMA: | 104.85 | Buy |
Verisk Analytics Earnings Growth & VRSK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.10 per share, an increase this year of $0.40 per share, and an increase next year of $0.86 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Verisk Analytics Technical Analysis
Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |